Manchester Royal Eye Hospital is the second largest Eye Hospital in the UK and benefits from being part of a major teaching hospital and its strong ties with The University of Manchester.
We conduct a broad range of research from laboratory studies, through original development in new technology, diagnostics and treatments to a role in global clinical trials on new treatments for ocular disease. In addition to developing new technologies, we have a strong background in assessing the latest global devices and investigative medicinal products
Our team of research coordinators and administrators work with consultants, doctors, optometrists and ophthalmic scientists to deliver research at the hospital.
We currently support over 15 open NIHR portfolio studies and have many years of experience in managing commercial and non-commercial clinical trials (CTIMPs, non-CTIMPs and devices) and research studies, particularly in the areas of:
- Cataract
- Cornea
- Emergency Eye Research
- Genetics
- Glaucoma
- Low Vision/Optometry
- Neuro Ophthalmology
- Oculoplastic/Oculoprosthetics
- Orthoptic
- Other
- Paediatric
- Retina (Diabetic, Medical Retina, Surgical Retina/Vitreoretinal)
- Uveitis
Our team also provide ophthalmic services for research to other departments and hospitals within MFT and other hospitals within Greater Manchester, including The Christie NHS Foundation Trust.
Our patients are often the first in the world or in Europe to have the opportunity to trial new treatments.
We recruited the:
- First UK patient to the EDF ILI875 study,
- First EU patients to the SUMMIT and PROMETHEUS studies,
- First EMEA (Europe, the Middle East and Africa) to the Gilead study
- First global patients to the Second Sight Argus II Feasibility Study in Dry AMD, SAFARI, INJECT and HYDRUS IV studies, amongst others.